Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Eric Schmidt's Stock Ratings
Cantor Fitzgerald Analyst
Eric Schmidt is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/24/2025
Overall Average Return
-31.0%
Smart Score
Overall Average Return Percentile
8th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2025 | SMMT | Buy Now | Summit Therapeutics | $33.79 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2025 | IMTX | Buy Now | Immatics | $4.54 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 03/21/2025 | SMMT | Buy Now | Summit Therapeutics | $33.79 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 03/21/2025 | GLYC | Buy Now | GlycoMimetics | $0.24 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 03/20/2025 | ALMS | Buy Now | Alumis | $4.67 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 03/13/2025 | BCAX | Buy Now | Bicara Therapeutics | $15.51 | -16.12% | Eric Schmidt30% | $13.01 → $13.01 | Reiterates | Overweight → Overweight | Get Alert |
| 03/07/2025 | ADCT | Buy Now | ADC Therapeutics | $1.33 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/21/2025 | PRTA | Buy Now | Prothena Corp | $9.82 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | CRSP | Buy Now | CRISPR Therapeutics | $39.12 | — | Eric Schmidt30% | — | Reiterates | Neutral → Neutral | Get Alert |
| 01/27/2025 | CDTX | Buy Now | Cidara Therapeutics | $21.27 | — | Eric Schmidt30% | — | Assumes | → Overweight | Get Alert |
| 01/10/2025 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Reiterates | Neutral → Neutral | Get Alert |
| 12/18/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $28.73 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/05/2024 | TNGX | Buy Now | Tango Therapeutics | $1.46 | — | Eric Schmidt30% | — | Reiterates | Overweight → Overweight | Get Alert |
| 11/19/2024 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 11/14/2024 | ALMS | Buy Now | Alumis | $4.67 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 10/08/2024 | BCAX | Buy Now | Bicara Therapeutics | $15.51 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 09/20/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $28.73 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 09/18/2024 | RNA | Buy Now | Avidity Biosciences | $30.36 | 216.21% | Eric Schmidt30% | $96 → $96 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | RNA | Buy Now | Avidity Biosciences | $30.36 | 216.21% | Eric Schmidt30% | $96 → $96 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 09/16/2024 | BLUE | Buy Now | bluebird bio | $4.08 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 09/09/2024 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 09/09/2024 | IMTX | Buy Now | Immatics | $4.54 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $29.54 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | RNA | Buy Now | Avidity Biosciences | $30.36 | 216.21% | Eric Schmidt30% | $96 → $96 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | BIIB | Buy Now | Biogen | $119.14 | 145.1% | Eric Schmidt30% | $292 → $292 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | IMTX | Buy Now | Immatics | $4.54 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 08/19/2024 | ALMS | Buy Now | Alumis | $4.67 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 08/08/2024 | CRSP | Buy Now | CRISPR Therapeutics | $39.12 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 07/23/2024 | ALMS | Buy Now | Alumis | $4.67 | — | Eric Schmidt30% | → $13 | Initiates | → Overweight | Get Alert |
| 07/09/2024 | TNGX | Buy Now | Tango Therapeutics | $1.46 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 06/17/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $28.73 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 05/30/2024 | ADCT | Buy Now | ADC Therapeutics | $1.33 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $39.12 | — | Eric Schmidt30% | — | Reiterates | → Neutral | Get Alert |
| 04/23/2024 | INCY | Buy Now | Incyte | $58.10 | — | Eric Schmidt30% | — | Initiates | → Neutral | Get Alert |
| 04/09/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $28.73 | — | Eric Schmidt30% | — | Reiterates | → Overweight | Get Alert |
| 04/04/2024 | TNGX | Buy Now | Tango Therapeutics | $1.46 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 03/14/2024 | RNA | Buy Now | Avidity Biosciences | $30.36 | 97.63% | Eric Schmidt30% | → $60 | Initiates | → Overweight | Get Alert |
| 02/20/2024 | BIIB | Buy Now | Biogen | $119.14 | 161.05% | Eric Schmidt30% | $311 → $311 | Reiterates | Overweight → Overweight | Get Alert |
| 12/20/2023 | BIIB | Buy Now | Biogen | $119.14 | 161.05% | Eric Schmidt30% | $311 → $311 | Reiterates | Overweight → Overweight | Get Alert |
| 11/02/2023 | IMTX | Buy Now | Immatics | $4.54 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 11/02/2023 | IMCR | Buy Now | Immunocore Hldgs | $29.54 | — | Eric Schmidt30% | — | Initiates | → Overweight | Get Alert |
| 10/17/2023 | BLUE | Buy Now | bluebird bio | $4.08 | — | Eric Schmidt30% | — | Initiates | → Neutral | Get Alert |
| 10/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $39.12 | — | Eric Schmidt30% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/17/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $492.61 | -24.89% | Eric Schmidt30% | → $370 | Reiterates | Overweight → Overweight | Get Alert |
| 10/17/2023 | EDIT | Buy Now | Editas Medicine | $1.54 | — | Eric Schmidt30% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/10/2017 | BIVV | Buy Now | Bioverativ | — | — | Eric Schmidt30% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/12/2017 | GTHX | Buy Now | G1 Therapeutics | — | — | Eric Schmidt30% | → $31 | Initiates | → Outperform | Get Alert |
| 05/30/2017 | OVID | Buy Now | Ovid Therapeutics | $0.35 | — | Eric Schmidt30% | — | Initiates | → Outperform | Get Alert |
